.jpg)
Cp2d Listing
3fa2e438-2ff0-a2df-e063-6394a90ac7b5
34391-3
HUMAN PRESCRIPTION DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Intended for use only with automated red cell apheresis devices to collect red blood cells and plasma (FFP and PF24).
Warnings and Precautions
Warnings Not for direct intravenous infusion. Single-use container – discard unused portion. (do not reuse) Do not use unless the solution is clear and no leaks are detected. Precautions Use only with automated red-cell apheresis devices and follow the Operator’s Manual. Refer to the package insert for complete instructions. Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing. Pouch is a moisture barrier; handle to maintain package integrity.
Storage and Handling
Store at room temperature (25 °C/77 °F). Avoid excessive heat. Protect from freezing.
Medication Information
Warnings and Precautions
Warnings
Not for direct intravenous infusion.
Single-use container – discard unused portion. (do not reuse)
Do not use unless the solution is clear and no leaks are detected.
Precautions
Use only with automated red-cell apheresis devices and follow the Operator’s Manual.
Refer to the package insert for complete instructions.
Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing.
Pouch is a moisture barrier; handle to maintain package integrity.
Storage and Handling
Store at room temperature (25 °C/77 °F). Avoid excessive heat. Protect from freezing.
Description
Intended for use only with automated red cell apheresis devices to collect red blood cells and plasma (FFP and PF24).
Section 60560-0
Intended for use only with automated red cell apheresis devices
to collect red blood cells and plasma (FFP and PF24).
Package Label
Manufacturer information: GVS TM Inc.
1630 W Industrial Park St
Covina, CA 91722, USA
ANTICOAGULANT CITRATE PHOSPHATE DOUBLE
DEXTROSE SOLUTION (CP2D), 250 mL
Intended for use only with automated red cell apheresis devices
to collect red blood cells and plasma (FFP and PF24). See the
appropriate Operator’s Manual for additional information and
complete usage instructions.
Each 100 mL contains:
Citric Acid (Monohydrate), USP 0.327 g
Sodium Citrate (Dihydrate), USP 2.630 g
Monobasic Sodium Phosphate (Monohydrate), USP 0.222 g
Dextrose (Anhydrous), USP 4.640 g
CAUTION: Refer to package insert. Not for direct intravenous
infusion. The pouch is a moisture barrier.
Do not use unless solution is clear and no leaks detected.
Single use container. Discard unused portion.
Sterile, nonpyrogenic fluid path. Sterilized by steam. Rx Only.
Store at room temperature (25 °C/77 °F). Avoid excessive heat.
Protect from freezing.
REF: 0455A-00
lot and expiry date
126616-00 REV.0 - template number
Description Section
ANTICOAGULANT CITRATE PHOSPHATE DOUBLE
DEXTROSE SOLUTION (CP2D), 250 mL
0455A-00
Statement of Identity
ANTICOAGULANT CITRATE PHOSPHATE DOUBLE
DEXTROSE SOLUTION (CP2D), 250 mL
0455A-00
Storage and Handling Section
Store at room temperature (25 °C/77 °F). Avoid excessive heat.
Protect from freezing.
Structured Label Content
Section 60560-0 (60560-0)
Intended for use only with automated red cell apheresis devices
to collect red blood cells and plasma (FFP and PF24).
Package Label (Package label)
Manufacturer information: GVS TM Inc.
1630 W Industrial Park St
Covina, CA 91722, USA
ANTICOAGULANT CITRATE PHOSPHATE DOUBLE
DEXTROSE SOLUTION (CP2D), 250 mL
Intended for use only with automated red cell apheresis devices
to collect red blood cells and plasma (FFP and PF24). See the
appropriate Operator’s Manual for additional information and
complete usage instructions.
Each 100 mL contains:
Citric Acid (Monohydrate), USP 0.327 g
Sodium Citrate (Dihydrate), USP 2.630 g
Monobasic Sodium Phosphate (Monohydrate), USP 0.222 g
Dextrose (Anhydrous), USP 4.640 g
CAUTION: Refer to package insert. Not for direct intravenous
infusion. The pouch is a moisture barrier.
Do not use unless solution is clear and no leaks detected.
Single use container. Discard unused portion.
Sterile, nonpyrogenic fluid path. Sterilized by steam. Rx Only.
Store at room temperature (25 °C/77 °F). Avoid excessive heat.
Protect from freezing.
REF: 0455A-00
lot and expiry date
126616-00 REV.0 - template number
Description Section (Description section)
ANTICOAGULANT CITRATE PHOSPHATE DOUBLE
DEXTROSE SOLUTION (CP2D), 250 mL
0455A-00
Statement of Identity (Statement of identity)
ANTICOAGULANT CITRATE PHOSPHATE DOUBLE
DEXTROSE SOLUTION (CP2D), 250 mL
0455A-00
Warnings and Precautions (Warnings and precautions)
Warnings
Not for direct intravenous infusion.
Single-use container – discard unused portion. (do not reuse)
Do not use unless the solution is clear and no leaks are detected.
Precautions
Use only with automated red-cell apheresis devices and follow the Operator’s Manual.
Refer to the package insert for complete instructions.
Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing.
Pouch is a moisture barrier; handle to maintain package integrity.
Storage and Handling Section (Storage and handling section)
Store at room temperature (25 °C/77 °F). Avoid excessive heat.
Protect from freezing.
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T11:49:58.772490 · Updated: 2026-03-14T22:49:12.025925